The Need to Target Mucosa-Associated Lymphoid Tissue for Preventing Lymphoma in Rheumatoid Factor-Positive Patients With Sjögren's Syndrome: Comment on the Article by Nocturne et al
Arthritis Rheumatol
.
2016 May;68(5):1318-9.
doi: 10.1002/art.39585.
Authors
Luca Quartuccio
1
,
Chiara Baldini
2
,
Stefano Bombardieri
2
,
Roberta Priori
3
,
Guido Valesini
3
,
Elena Bartoloni
4
,
Alessia Alunno
,
Roberto Gerli
4
,
Francesco Carubbi
5
,
Roberto Giacomelli
5
,
Salvatore De Vita
1
Affiliations
1
University of Udine, Udine, Italy.
2
University of Pisa, Pisa, Italy.
3
University of Perugia, Perugia, Italy.
4
Sapienza University of Rome, Rome, Italy.
5
University of L'Aquila, L'Aquila, Italy.
PMID:
26749397
DOI:
10.1002/art.39585
No abstract available
Publication types
Letter
Comment
MeSH terms
Humans
Lymphoid Tissue
Lymphoma, B-Cell, Marginal Zone
Mucous Membrane
Rheumatoid Factor*
Sjogren's Syndrome*
Substances
Rheumatoid Factor